Skip to main content
OpenTrials
Completed

NCT Number: NCT07513896

Factors Predicting The Success of Ejaculation Sparing Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients

evaluate the factors predicting the success of ejaculation-sparing TURP in patients with BPH after surgery, in terms of voiding improvement and preserved ejaculation post-operatively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Benign Prostatic Hyperplasia Ejaculation Genital Diseases Genital Diseases, Male Male Urogenital Diseases Prostatic Diseases Prostatic Hyperplasia Urogenital Diseases

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

AinShams University

Cairo, Cairo Governorate, 11566, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • sexually active male patient with normal ejaculatory function
  • upper urinary tract affection and renal insufficiency.
  • Chronic Urinary Retention
  • Patients with failed medical therapy.
  • Patients not compliant to medical treatment
  • Patients with recurrent hematuria or recurrent lower urinary tract infections

Exclusion criteria

  • Patients with an anterior urethral stricture
  • Patients with history of urethral operations
  • Patients with previous prostatic surgery
  • Patients with neurological disorders
  • Non sexually active patients

Treatment and study plan

ejaculatory preserving TURP

Procedure

In our study, we performed an EP-TURP technique, which is adopted in our institute and involves the preservation of 1 cm of urethral mucosa all around the verumontanum, including the prostatic apical urethral mucosa, with adequate resection of the prostatic adenoma, including the apical prostatic tissue, which was resected lateral to the spared urethral mucosa to ensure adequate management of the outflow obstruction. (8). Bi-polar TURP was performed using a 26 Fr. Resectoscope (Karl Storz, Tuttlingen, Germany) and Karl Storz- AUTOCON® IV.

Intraoperative cystoscopic evaluation and documentation of the prostatic anatomy were done. SML was measured cystoscopically using a 22 Fr sheath with centimeter markings. Operative time, perioperative complications, catheterization duration, and hospital stay were recorded. Urethral catheter removal was planned after 24-48 hours unless prolonged catheterization was clinically indicated.

Primary outcomes

  1. Preservation of antegrade ejaculation at 3 months

    Time frame: 3 months

    The primary outcome was to assess the post operative ejaculation at 3 months using Male Sexual Health Questionnaire for ejaculatory dysfunction short form (MSHQ-Ej.D-SF).

Secondary outcomes

  1. post-operative post-voiding residual volume

    Time frame: 3 months

    Measurement of post-operative post-voiding residual volume by Pelvi-abdominal Ultrasound

Other outcomes

  1. post operative complication

    Time frame: 3 months

    assess post operative complications using Clavien-Dindo classification for TURP

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Apr 7, 2026
Registry last updated
Apr 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.